Oramed Pharmaceuticals And ORMD-0901 [Seeking Alpha]
Oramed Pharmaceuticals Inc. (ORMP)
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm
Check Earnings Report
US:NASDAQ Investor Relations:
oramed.com/investors
Company Research
Source: Seeking Alpha
Oramed Pharmaceuticals And ORMD-0901 Summary Liver Therapy Forum weekly digest provides an overview of what's happening in therapeutics for endocrine disorders in 2019. The focus this week is Oramed Pharmaceuticals. ORMD-0901 is an oral glucagon-like peptide-1 analog in clinical evaluation for the treatment of type 2 diabetes. Glucagon-like peptide-1 are metabolic hormones that increase insulin secretion to decrease blood glucose levels after a meal. ORMD-0901 enters Phase 2 clinical development for type 2 diabetes in 2020. Market Assessment Oramed Pharmaceuticals ( ORMP This article focuses on ORMD-0901 Glucagon-like peptide (GLP.)-1 is derived from proglucagon, via proteolytic processing resulting in a biologically active form consisting of 30 amino acids. As a gut hormone, GLP-1 is secreted by the endocrine cells located in the epithelium of the small intestine cells in response to a meal to decrease blood glucose. An effect that enhances the secretion of insulin from pancreatic be
Show less
Read more
Impact Snapshot
Event Time:
ORMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORMP alerts
High impacting Oramed Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ORMP
News
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company DebtPR Newswire
ORMP
Earnings
- 8/14/24 - Beat
ORMP
Analyst Actions
- 9/9/24 - HC Wainwright
ORMP
Sec Filings
- 11/8/24 - Form 4
- 11/8/24 - Form 4
- 11/8/24 - Form 4
- ORMP's page on the SEC website